Bipolar disorder
Read the topic background here, then explore the labeled visual and structured learning explanations on this page.
Read explanation on this page ↓ See diagram ↓Bipolar disorder — on-site reading
An introductory overview for this topic. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.
Bipolar disorder (BD), previously known as manic depression, is a mental disorder characterized by periods of depression and abnormally elevated mood, lasting days to weeks, and in some cases months. If the elevated mood is severe or associated with psychosis, it is called mania; if it does not significantly affect functioning, it is called hypomania. During mania, an individual behaves or feels abnormally energetic, happy, or irritable, and often makes impulsive and reckless decisions. There is usually sleep disturbance during manic phases. During periods of depression, the individual may experience crying, have a negative outlook, and demonstrate poor eye contact. People with BD are at 11.7 times greater risk of dying by suicide than the general population. Approximately 34% attempt suicide during their lifetime. Among adolescents with BD, 78% engaged in self-harm.
The mechanisms of this mood disorder are not clearly understood, although some studies suggest areas for future clinical research. Structural and functional MRI studies have shown differences in brain regions in BD, such as regions involved in perceiving risk-reward and regulating emotions. A systematic review and meta-analysis by Murri and others found that cortisol levels are "associated with the manic phase" of BD. Likewise, various other studies support an important role for hypothalamic-pituitary-adrenal axis (HPA axis).
Risk for BD is thought to be influenced by genetics, environment, and ADHD. In one respect (heritability), genetic factors may account for up to 70–90% of the risk of developing BD. In another respect (concordance rate), identical twins both have bipolar disorder (or both do not) at a rate of ~40%, in contrast to dizygotic twins' ~5%. Environmental risks include a history of child abuse and long-term stress. A meta-analysis and a separate critical literature review have found worse prognosis and earlier onset of BD in people with childhood maltreatment and "early emotional trauma" respectively. Likewise, traumatic bonding increases risk of BD. ADHD increases the risk of developing bipolar disorder. More research is needed to understand the nature of this association.
The condition is classified as bipolar I disorder if there has been at least one manic episode, with or without depressive episodes, and as bipolar II disorder if there has been at least one hypomanic episode (but no full manic episodes) and one major depressive episode. It is classified as cyclothymia if there are hypomanic symptoms with periods of depression that do not meet the criteria for major depressive episodes. If these symptoms are due to drugs or medical problems, they are not diagnosed as BD.
Mood stabilizers, particularly lithium, and anticonvulsants, such as lamotrigine and valproate, as well as atypical antipsychotics are used for treatment. Atypical antipsychotics are used for acute manic episodes or when mood stabilizers are ineffective or not tolerated, with long-acting injectables available for patients who struggle to maintain a medication regimen. There is evidence that psychotherapy improves the course of BD. Use of antidepressants in depressive episodes is controversial: they can be effective, but certain classes of antidepressants increase the risk of mania. The treatment of depressive episodes, therefore, is often difficult. Past studies have found that electroconvulsive therapy (ECT) is effective in acute manic and depressive episodes, particularly with psychosis or catatonia; likewise, past guidelines have recommended admission to a psychiatric hospital if someone is a risk to themselves or others, or involuntary treatment if someone refuses treatment. However, the Committee on Rights of Persons with Disabilities (CRPD) of the United Nations has recommended the abolition of institutionalization and forced treatments "such as sedatives, mood stabilizers, electro-convulsive treatment, and conversion therapy".
The 6–12 month prevalence of bipolar disorder is 1%, while the lifetime prevalence is between 1 and 3%. The prevalence of pediatric bipolar disorder is 3.9%, although study estimates are higher with "broad bipolar criteria" and "older minimum age". The most frequent ages of onset are 24 or 46; the distribution of onset age is bimodal. An earlier onset is associated with worse depression and more frequent co-diagnosis of anxiety and substance use. Around 40–60% of people with BD are employed and over 80% "may take time off work for psychiatric reasons in a five year period." Occupational therapies appear cost-effective at returning people with BD to work. Social cognition is moderately impaired in people with BD, regardless of mood state. 16% of people with BD are high functioning. As of 2021, people with BD accounted for 183 Years Lived with Disability (YLDs) per 100,000 people in the Americas (ranking 20th out of all conditions). Risk of death due to unnatural and natural causes is 7.3 and 1.9 times higher respectively. On average, life expectancy is 12.9 years shorter.
How this connects to Psychiatry
Mental-health assessment evaluates reported experiences, cognitive and behavioral patterns, medical and developmental context and functional effects over time. Biological, psychological and social factors interact; a checklist or one visible behavior does not establish a diagnosis.
Text credit: Wikipedia contributors, “Bipolar disorder”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.
Bipolar disorder · visual study map
Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).
What the underlying subject studies
Psychiatry integrates the history of psychological experiences, observed behavior, cognition, functioning and medical or social context. A diagnosis cannot be inferred from one behavior or appearance.
How mechanisms and evidence connect
Neurobiological, developmental, environmental, medical and interpersonal factors can interact. Assessment includes time course, differential diagnosis, strengths, safety concerns and the person’s own account.
How to develop a sound explanation
Study disorders through characteristic symptom patterns, functional impact, competing explanations and evidence-based assessment and treatment principles. Patient care requires respectful clinical evaluation, not a checklist alone.
References and verification (optional)
All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.
NMC official CBME Curriculum 2024 and current regulations index ↗